|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cai Q, Chen Y, Xin S, Zhang D, Pan J, Xie
Z, Xu C, Li S, Zhang X, Gao Y, et al: Temporal trends of bladder
cancer incidence and mortality from 1990 to 2016 and projections to
2030. Transl Androl Urol. 9:153–165. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhou B, Zhang P, Wang Y, Shi S, Zhang K,
Liao H and Zhang L: Interleukin-17 gene polymorphisms are
associated with bladder cancer in a Chinese Han population. Mol
Carcinog. 52:871–878. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pençe S, Özbek E, Ozan Tiryakioğlu N and
Ersoy Tunali N: Deregulation of seven CpG island-harboring miRNAs
in bladder cancer: miR-155 and miR-23b as the most promising
oncomiRs. Cell Mol Biol (Noisy-le-grand). 62:25–30. 2016.
|
|
5
|
Wang L, Smith BA, Balanis NG, Tsai BL,
Nguyen K, Cheng MW, Obusan MB, Esedebe FN, Patel SJ, Zhang H, et
al: A genetically defined disease model reveals that urothelial
cells can initiate divergent bladder cancer phenotypes. Proc Natl
Acad Sci USA. 117:563–572. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Deng YB, Nagae G, Midorikawa Y, Yagi K,
Tsutsumi S, Yamamoto S, Hasegawa K, Kokudo N, Aburatani H and
Kaneda A: Identification of genes preferentially methylated in
hepatitis C virus-related hepatocellular carcinoma. Cancer Sci.
101:1501–1510. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou N, Singh K, Mir MC, Parker Y, Lindner
D, Dreicer R, Ecsedy JA, Zhang Z, Teh BT, Almasan A and Hansel DE:
The investigational aurora kinase A inhibitor MLN8237 induces
defects in cell viability and cell-cycle progression in malignant
bladder cancer cells in vitro and in vivo. Clin Cancer Res.
19:1717–1728. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Borisov N, Tkachev V, Suntsova M,
Kovalchuk O, Zhavoronkov A, Muchnik I and Buzdin A: A method of
gene expression data transfer from cell lines to cancer patients
for machine-learning prediction of drug efficiency. Cell Cycle.
17:486–491. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Edgar R, Domrachev M and Lash AE: Gene
expression omnibus: NCBI gene expression and hybridization array
data repository. Nucleic Acids Res. 30:207–210. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Franceschini A, Szklarczyk D, Frankild S,
Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C
and Jensen LJ: STRING v9.1: Protein-protein interaction networks,
with increased coverage and integration. Nucleic Acids Res.
41((Database Issue)): D808–D815. 2013.PubMed/NCBI
|
|
11
|
Smoot ME, Ono K, Ruscheinski J, Wang PL
and Ideker T: Cytoscape 2.8: New features for data integration and
network visualization. Bioinformatics. 27:431–432. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bandettini WP, Kellman P, Mancini C,
Booker OJ, Vasu S, Leung SW, Wilson JR, Shanbhag SM, Chen MY and
Arai AE: MultiContrast delayed enhancement (MCODE) improves
detection of subendocardial myocardial infarction by late
gadolinium enhancement cardiovascular magnetic resonance: A
clinical validation study. J Cardiovasc Magn Reson. 14:832012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang DW, Sherman BT, Tan Q, Collins JR,
Alvord WG, Roayaei J, Stephens R, Baseler MW, Lane HC and Lempicki
RA: The DAVID gene functional classification tool: A novel
biological module-centric algorithm to functionally analyze large
gene lists. Genome Biol. 8:R1832007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The gene
ontology consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kanehisa M: The KEGG database. Novartis
Found Symp. 247:91–103, 119-128, 244–152. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chin CH, Chen SH, Wu HH, Ho CW, Ko MT and
Lin CY: cytoHubba: Identifying hub objects and sub-networks from
complex interactome. BMC Syst Biol. 8 (Suppl 4):S112014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Maere S, Heymans K and Kuiper M: BiNGO: A
cytoscape plugin to assess overrepresentation of gene ontology
categories in biological networks. Bioinformatics. 21:3448–3449.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kent WJ, Sugnet CW, Furey TS, Roskin KM,
Pringle TH, Zahler AM and Haussler D: The human genome browser at
UCSC. Genome Res. 12:996–1006. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dyrskjøt L, Kruhøffer M, Thykjaer T,
Marcussen N, Jensen JL, Møller K and Ørntoft TF: Gene expression in
the urinary bladder: A common carcinoma in situ gene expression
signature exists disregarding histopathological classification.
Cancer Res. 64:4040–4048. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee JS, Leem SH, Lee SY, Kim SC, Park ES,
Kim SB, Kim SK, Kim YJ, Kim WJ and Chu IS: Expression signature of
E2F1 and its associated genes predict superficial to invasive
progression of bladder tumors. J Clin Oncol. 28:2660–2667. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sanchez-Carbayo M, Socci ND, Lozano J,
Saint F and Cordon-Cardo C: Defining molecular profiles of poor
outcome in patients with invasive bladder cancer using
oligonucleotide microarrays. J Clin Oncol. 24:778–789. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Stransky N, Vallot C, Reyal F,
Bernard-Pierrot I, de Medina SG, Segraves R, de Rycke Y, Elvin P,
Cassidy A, Spraggon C, et al: Regional copy number-independent
deregulation of transcription in cancer. Nat Genet. 38:1386–1396.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Singer J, Irmisch A, Ruscheweyh HJ, Singer
F, Toussaint NC, Levesque MP, Stekhoven DJ and Beerenwinkel N:
Bioinformatics for precision oncology. Brief Bioinform. 20:778–788.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li PC: Overview of microarray technology.
Methods Mol Biol. 1368:3–4. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Whitehead CM and Rattner JB: Expanding the
role of HsEg5 within the mitotic and post-mitotic phases of the
cell cycle. J Cell Sci. 111:2551–2561. 1998.PubMed/NCBI
|
|
28
|
Imai T, Oue N, Nishioka M, Mukai S, Oshima
T, Sakamoto N, Sentani K, Matsusaki K, Yoshida K and Yasui W:
Overexpression of KIF11 in gastric cancer with intestinal mucin
phenotype. Pathobiology. 84:16–24. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Daigo K, Takano A, Thang PM, Yoshitake Y,
Shinohara M, Tohnai I, Murakami Y, Maegawa J and Daigo Y:
Characterization of KIF11 as a novel prognostic biomarker and
therapeutic target for oral cancer. Int J Oncol. 52:155–165.
2018.PubMed/NCBI
|
|
30
|
Zhou J, Chen WR, Yang LC, Wang J, Sun JY,
Zhang WW, He ZY and Wu SG: KIF11 functions as an oncogene and is
associated with poor outcomes from breast cancer. Cancer Res Treat.
51:1207–1221. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jungwirth G, Yu T, Moustafa M, Rapp C,
Warta R, Jungk C, Sahm F, Dettling S, Zweckberger K, Lamszus K, et
al: Identification of KIF11 as a novel target in meningioma.
Cancers (Basel). 11:5452019. View Article : Google Scholar
|
|
32
|
Jin Q, Dai Y, Wang Y, Zhang S and Liu G:
High kinesin family member 11 expression predicts poor prognosis in
patients with clear cell renal cell carcinoma. J Clin Pathol.
72:354–362. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Piao XM, Byun YJ, Jeong P, Ha YS, Yoo ES,
Yun SJ and Kim WJ: Kinesin family member 11 mRNA expression
predicts prostate cancer aggressiveness. Clin Genitourin Cancer.
15:450–454. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen L, Yuan L, Qian K, Qian G, Zhu Y, Wu
CL, Dan HC, Xiao Y and Wang X: Identification of biomarkers
associated with pathological stage and prognosis of clear cell
renal cell carcinoma by co-expression network analysis. Front
Physiol. 9:3992018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Burgess EF, Livasy C, Trufan S, Hartman A,
Guerreri R, Naso C, Clark PE, Grigg C, Symanowski J and Raghavan D:
High aurora kinase expression identifies patients with
muscle-invasive bladder cancer who have poor survival after
neoadjuvant chemotherapy. Urol Oncol. 37:900–906. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Heo J, Noh BJ, Lee S, Lee HY, Kim Y, Lim
J, Ju H, Yu HY, Ryu CM, Lee PC, et al: Phosphorylation of TFCP2L1
by CDK1 is required for stem cell pluripotency and bladder
carcinogenesis. EMBO Mol Med. 12:e108802020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lei CY, Wang W, Zhu YT, Fang WY and Tan
WL: The decrease of cyclin B2 expression inhibits invasion and
metastasis of bladder cancer. Urol Oncol. 34:237.e1–e10. 2016.
View Article : Google Scholar
|
